
IndraLab
Statements
reach
"The synthetic protease inhibitor bis [ethyl (2R,3 R)-3-[(S)-methyl-1-[4-(2,3,4-tri-methoxyphenyl-methyl) piperazine-1-ylcarbonyl] butyl-carbonyl] oxiran-2-carboxylate] sulfate (NCO-700) suppressed both activities of calcium activated neutral protease and cathepsin B isolated from cardiac muscle, showing 50% inhibition at 46 and 0.8 mumol/l, respectively."